Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;15(3):473-8.
doi: 10.1007/s12253-008-9132-y.

Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis

Affiliations
Free article

Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis

Weijie Yuan et al. Pathol Oncol Res. 2009 Sep.
Free article

Abstract

In this study, gastric cancer progression was correlated with the over-expression of erythropoietin-producing hepatocellular (Eph)A2 receptor and down-expression of epithelial cadherin (E-cadherin). Immunohistochemistry of EphA2 and E-cadherin were performed on these tumor samples from 165 primary lesions of gastric cancer. The results showed that expression of EphA2 was obviously increased in gastric cancer tissues (P < 0.01), which was positively correlated with the depth of cancer invasion, tumor-node-metastasis (TNM) stage and lymph node metastasis (P < 0.05). Meanwhile, the expression of E-cadherin was significantly reduced (P < 0.01), which was negatively correlated with the depth of cancer invasion, grade of tumor differentiation, TNM stage and lymph node metastasis (P < 0.05). The correlation between EphA2 and E-cadherin expression was negative (r = -0.198, P = 0.011). In conclusion, either the over-expression of EphA2 or the down-expression of E-cadherin is correlated with cancer progression and lymphogenous metastasis in gastric cancer, suggesting that both of them may play an important role in tumor progression and metastasis.

PubMed Disclaimer

References

    1. Genomics. 1997 Mar 1;40(2):371-4 - PubMed
    1. Oncol Rep. 2006 Oct;16(4):823-30 - PubMed
    1. Cancer Biol Ther. 2007 Feb;6(2):269-75 - PubMed
    1. Am J Pathol. 1991 Jul;139(1):17-23 - PubMed
    1. Clin Cancer Res. 2001 Nov;7(11):3640-8 - PubMed